New Zealand markets open in 3 hours 53 minutes

Xenon Pharmaceuticals Inc. (XENE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
40.54-1.95 (-4.59%)
At close: 04:00PM EDT
40.54 0.00 (0.00%)
After hours: 04:01PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 3.06B
Enterprise value 2.43B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)3.30
Enterprise value/revenue 10.87k
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-2.87%
S&P500 52-week change 326.27%
52-week high 350.99
52-week low 327.99
50-day moving average 342.82
200-day moving average 339.96

Share statistics

Avg vol (3-month) 3351.55k
Avg vol (10-day) 3328.18k
Shares outstanding 575.46M
Implied shares outstanding 676.33M
Float 869.56M
% held by insiders 10.38%
% held by institutions 1100.76%
Shares short (30 Apr 2024) 42.79M
Short ratio (30 Apr 2024) 48.13
Short % of float (30 Apr 2024) 43.72%
Short % of shares outstanding (30 Apr 2024) 43.69%
Shares short (prior month 28 Mar 2024) 42.76M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-17.09%
Return on equity (ttm)-23.95%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -219.97M
Net income avi to common (ttm)-188.6M
Diluted EPS (ttm)-2.73
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)699.6M
Total cash per share (mrq)9.27
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)31.82
Book value per share (mrq)11.78

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A